| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |